<?xml version="1.0" encoding="UTF-8"?>
<p>At the time of writing, there are no authorized cannabis or cannabis-derived veterinary medicinal products on the market in the EU, US, or Canada. On the EU market, one product is authorised in Germany (Cardio ReVet RV4) and registered as a homeopathic veterinary medicine [
 <xref rid="B93-animals-11-00892" ref-type="bibr">93</xref>]. In addition, one CBD product (Anibidiol) registered as a feed supplement is marketed in several EU Member States such as France and the Netherlands [
 <xref rid="B94-animals-11-00892" ref-type="bibr">94</xref>]. Anibidiol contains CBD and Vitamins B3 and B6. The leaflet mentions “
 <italic>Veterinarians have good experience in using this product for behavioural problems, pain, infection, epilepsy and the consequences of tumours in dogs and cats</italic>”. The product is available without the need for a veterinary prescription.
</p>
